<!DOCTYPE html>
<html class="client-js"><head>
  <meta charset=UTF-8"UTF-8">
  <title>Temozolomide</title>
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <script>
    function importScript() { return 1 } // this is to avoid the error from site.js
  </script>
  <link rel="canonical" href="https://en.wikipedia.org/wiki/Temozolomide">
  <link href="../-/s/css_modules/ext.cite.ux-enhancements.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.ux-enhancements.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/ext.cite.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/ext.cite.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/mediawiki.page.gallery.styles.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/mediawiki.page.gallery.styles.css" rel="stylesheet" type="text/css" class="">
<link href="../-/s/css_modules/fi000001.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/skins.minerva.base.reset|skins.minerva.content.styles|ext.cite.style|site.styles|mobile.app.pagestyles.android|mediawiki.page.gallery.styles|mediawiki.skinning.content.parsoid.css" rel="stylesheet" type="text/css" class="">
  <link href="../-/s/css_modules/style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/style.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/content.parsoid.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/content.parsoid.css" rel="stylesheet" type="text/css" class=""><link href="../-/s/css_modules/inserted_style.css" tppabs="https://ptable.com/wiki/compounds/-/s/css_modules/inserted_style.css" rel="stylesheet" type="text/css" class="">
  <script src="../-/j/js_modules/script.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/script.js" class=""></script><script src="../-/j/js_modules/masonry.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/masonry.min.js" class=""></script><script src="../-/j/js_modules/article_list_home.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/article_list_home.js" class=""></script><script src="../-/j/js_modules/images_loaded.min.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/images_loaded.min.js" class=""></script><script src="../-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/node_module/details-element-polyfill/dist/details-element-polyfill.js" class=""></script>
<link type="root" href=""></head>

<body class="mediawiki mw-hide-empty-elt ns-0 ns-subject stable skin-minerva action-view animations">
  <div id="mw-mf-viewport" class="feature-header-v2">
    <div id="mw-mf-page-center">
      <div id="content" class="mw-body">
        <a id="top"></a>
        <div id="bodyContent" class="content mw-parser-output">
          
          <div id="mw-content-text" style="direction: ltr;"><h1 class="section-heading" tabindex="0" aria-haspopup="true" data-section-id="0">
  <span class="mw-headline" id="title_0">Temozolomide</span>
</h1>
<div id="mf-section-0" class="mf-section-0" aria-pressed="true" aria-expanded="true">
  <p><b>Temozolomide</b> (<b>TMZ</b>), sold under the brand name <b>Temodar</b> among others, is a medication used to treat some brain tumors such as glioblastoma multiforme or anaplastic astrocytoma.<span class="mw-ref" id="cite_ref-Temodar_FDA_label_3-0"><a href="#cite_note-Temodar_FDA_label-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-Temodal_EPAR_4-0"><a href="#cite_note-Temodal_EPAR-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> It is taken by mouth or via intravenous infusion.<span class="mw-ref" id="cite_ref-Temodar_FDA_label_3-1"><a href="#cite_note-Temodar_FDA_label-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-Temodal_EPAR_4-1"><a href="#cite_note-Temodal_EPAR-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>


<table class="infobox" style="width:22em;border-spacing:2px;"><caption><span>Temozolomide</span></caption><tbody><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Temozolomide_structure.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Temozolomide_structure.svg.png" data-file-width="512" data-file-height="448" data-file-type="drawing" height="140" width="160"></figure-inline></td></tr><tr><td colspan="2" style="text-align:center"><figure-inline><img src="../I/m/Temozolomide-3D-spacefill.png" tppabs="https://ptable.com/wiki/compounds/I/m/Temozolomide-3D-spacefill.png" data-file-width="2000" data-file-height="1799" data-file-type="bitmap" height="144" width="160"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Clinical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Trade names</th><td>Temodar, Temodal, Temcad, others<span class="mw-ref" id="cite_ref-1"><a href="#cite_note-1" style="counter-reset: mw-Ref 1;"><span class="mw-reflink-text">[1]</span></a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">AHFS/Drugs.com</th><td><span><a href="javascript:if(confirm('https://www.drugs.com/monograph/temozolomide.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/monograph/temozolomide.html'" tppabs="https://www.drugs.com/monograph/temozolomide.html" class="external text external">Monograph</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">MedlinePlus</th><td><span><a href="javascript:if(confirm('https://medlineplus.gov/druginfo/meds/a601250.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://medlineplus.gov/druginfo/meds/a601250.html'" tppabs="https://medlineplus.gov/druginfo/meds/a601250.html" class="external text external">a601250</a></span></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">License data</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">EU</abbr></small><span>&nbsp;</span>EMA:<span>&nbsp;</span><span><a href="javascript:if(confirm('http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Temozolomide  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Temozolomide'" tppabs="http://www.ema.europa.eu/ema/index.jsp?curl=%2Fpages%2Fmedicines%2Flanding%2Fepar_search.jsp&mid=&searchTab=searchByKey&alreadyLoaded=true&isNewQuery=true&status=Authorised&status=Withdrawn&status=Suspended&status=Refused&keywordSearch=Submit&searchType=inn&taxonomyPath=&treeNumber=&searchGenericType=generics&keyword=Temozolomide" class="external text external">by INN</a></span></li>
<li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span>DailyMed:<span>&nbsp;</span><span><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Temozolomide  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Temozolomide'" tppabs="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=Temozolomide" class="external text external">Temozolomide</a></span></li>
<li><small><abbr class="country-name">US</abbr></small><span>&nbsp;</span><span>FDA:<span>&nbsp;</span><a href="javascript:if(confirm('https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Temozolomide&SearchType=BasicSearch  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Temozolomide&SearchType=BasicSearch'" tppabs="https://www.accessdata.fda.gov/scripts/cder/drugsatfda/index.cfm?fuseaction=Search.SearchAction&SearchTerm=Temozolomide&SearchType=BasicSearch" class="external text external">Temozolomide</a></span></li></ul></div>
</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Pregnancy<br>category</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">AU</abbr>:</small><span> </span>D<span> </span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>D (Evidence of risk)<span> </span></li></ul>

<ul></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Routes of<br>administration</th><td>By mouth, intravenous</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ATC code</th><td><div class="plainlist"><ul><li>L01AX03<span> </span>(<span><a href="javascript:if(confirm('https://www.whocc.no/atc_ddd_index/?code=L01AX03  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.whocc.no/atc_ddd_index/?code=L01AX03'" tppabs="https://www.whocc.no/atc_ddd_index/?code=L01AX03" class="external text external">WHO</a></span>)<span> </span></li></ul></div></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Legal status</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Legal status</th><td><div class="plainlist">
<ul><li><small><abbr class="country-name">UK</abbr>:</small><span> </span>POM (Prescription only)<span> </span><span class="mw-ref" id="cite_ref-2"><a href="#cite_note-2" style="counter-reset: mw-Ref 2;"><span class="mw-reflink-text">[2]</span></a></span></li>
<li><small><abbr class="country-name">US</abbr>:</small><span> </span>℞-only<span> </span></li>
<li>In<span>&nbsp;</span>general: ℞<span>&nbsp;</span>(Prescription only)</li></ul></div>
</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Pharmacokinetic data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Bioavailability</th><td>almost 100%</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Protein binding</th><td>15% (10–20%)</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolism</th><td>hydrolysis</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Metabolites</th><td>3-methyl-(triazen-1-yl)imidazole-4-carboxamide (MTIC, the active species); temozolomide acid</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Elimination <span class="nowrap">half-life</span></th><td>1.8 hours</td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Excretion</th><td>mainly kidney</td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Identifiers</th></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">IUPAC name</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; text-align:left; padding-left:1.5em; text-indent:-1.5em; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><span style="font-size: 11px;">4-methyl-5-oxo-2,3,4,6,8-pentazabicyclo[4.3.0]nona-2,7,9-triene-9-carboxamide</span></li></ul>
</div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CAS Number</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.commonchemistry.org/ChemicalDetail.aspx?ref=85622-93-1  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.commonchemistry.org/ChemicalDetail.aspx?ref=85622-93-1'" tppabs="http://www.commonchemistry.org/ChemicalDetail.aspx?ref=85622-93-1" class="external text external">85622-93-1</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">PubChem <span style="font-weight:normal"><abbr>CID</abbr></span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://pubchem.ncbi.nlm.nih.gov/compound/5394  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubchem.ncbi.nlm.nih.gov/compound/5394'" tppabs="https://pubchem.ncbi.nlm.nih.gov/compound/5394" class="external text external">5394</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">IUPHAR/BPS</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7301  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7301'" tppabs="http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=7301" class="external text external">7301</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">DrugBank</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.drugbank.ca/drugs/DB00853  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugbank.ca/drugs/DB00853'" tppabs="https://www.drugbank.ca/drugs/DB00853" class="external text external">DB00853</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChemSpider</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('http://www.chemspider.com/Chemical-Structure.5201.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.chemspider.com/Chemical-Structure.5201.html'" tppabs="http://www.chemspider.com/Chemical-Structure.5201.html" class="external text external">5201</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">UNII</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=YF1K15M17Y  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=YF1K15M17Y'" tppabs="https://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=YF1K15M17Y" class="external text external">YF1K15M17Y</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">KEGG</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.kegg.jp/entry/D06067  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.kegg.jp/entry/D06067'" tppabs="https://www.kegg.jp/entry/D06067" class="external text external">D06067</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEBI</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:72564  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:72564'" tppabs="https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:72564" class="external text external">CHEBI:72564</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">ChEMBL</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL810  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL810'" tppabs="https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/ChEMBL810" class="external text external">ChEMBL810</a></span><sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">CompTox Dashboard <span style="font-weight:normal">(<abbr>EPA</abbr>)</span></th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://comptox.epa.gov/dashboard/DTXSID5043714  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://comptox.epa.gov/dashboard/DTXSID5043714'" tppabs="https://comptox.epa.gov/dashboard/DTXSID5043714" class="external text external">DTXSID5043714</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;"><span>ECHA InfoCard</span></th><td><a href="javascript:if(confirm('https://echa.europa.eu/substance-information/-/substanceinfo/100.158.652  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://echa.europa.eu/substance-information/-/substanceinfo/100.158.652'" tppabs="https://echa.europa.eu/substance-information/-/substanceinfo/100.158.652" class="external text external">100.158.652</a> <figure-inline class="mw-valign-text-top"><img src="../I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/OOjs_UI_icon_edit-ltr-progressive.svg.png" data-file-width="20" data-file-height="20" data-file-type="drawing" height="10" width="10"></figure-inline></td></tr><tr><th colspan="2" style="text-align:center;background:#ddd">Chemical and physical data</th></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Formula</th><td><span>C</span><sub>6</sub><span>H</span><sub>6</sub><span>N</span><sub>6</sub><span>O</span><sub>2</sub></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Molar mass</th><td>194.151<span>&nbsp;</span>g·mol<sup>−1</sup></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">3D model (JSmol)</th><td><div class="plainlist"><ul><li><span><a href="javascript:if(confirm('https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28c1ncn2C%28%3DO%29N%28%5CN%3DN%2Fc12%29C%29N  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28c1ncn2C%28%3DO%29N%28%5CN%3DN%2Fc12%29C%29N'" tppabs="https://chemapps.stolaf.edu/jmol/jmol.php?model=O%3DC%28c1ncn2C%28%3DO%29N%28%5CN%3DN%2Fc12%29C%29N" class="external text external">Interactive image</a></span></li></ul></div></td></tr><tr><th scope="row" style="padding:0.2em 0; line-height:1.2em;">Melting point</th><td>212<span>&nbsp;</span>°C (414<span>&nbsp;</span>°F) (decomp.)</td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">SMILES</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">O=C(c1ncn2C(=O)N(\N=N/c12)C)N</div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><div class="NavFrame collapsed" style="border: none; padding: 0;">
<div class="NavHead" style="font-size: 105%; background: transparent; text-align: left;">InChI</div>
<ul class="NavContent" style="list-style: none none; margin-left: 0; word-break:break-all; font-size: 105%; margin-top: 0; margin-bottom: 0; line-height: inherit;"><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">InChI=1S/C6H6N6O2/c1-11-6(14)12-2-8-3(4(7)13)5(12)9-10-11/h2H,1H3,(H2,7,13)<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li><li style="line-height: inherit; margin: 0"><div style="word-wrap:break-word; text-indent:-1.5em; text-align:left; padding-left:1.5em; font-size:11px; line-height:120%;">Key:BPEGJWRSRHCHSN-UHFFFAOYSA-N<sup><span>&nbsp;</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup></div></li></ul>
</div></td></tr><tr><td colspan="2" style="text-align:center"><style data-mw-deduplicate="TemplateStyles:r886047488">.mw-parser-output .nobold{font-weight:normal}</style><span class="nobold"><span>&nbsp;</span><sup><figure-inline><span><img src="../I/m/X_mark.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/X_mark.svg.png" data-file-width="525" data-file-height="600" data-file-type="drawing" height="8" width="7"></span></figure-inline><span style="display:none">N</span><figure-inline><span><img src="../I/m/Yes_check.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Yes_check.svg.png" data-file-width="600" data-file-height="600" data-file-type="drawing" height="7" width="7"></span></figure-inline><span style="display:none">Y</span></sup><span>&nbsp;</span>(what is this?)</span><span class="nobold"><span>&nbsp;</span><span>&nbsp;</span><span class="reflink  nourlexpansion"><a href="javascript:if(confirm('https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=477861554&page2=Temozolomide  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=477861554&page2=Temozolomide'" tppabs="https://en.wikipedia.org/w/index.php?title=Special:ComparePages&rev1=477861554&page2=Temozolomide" class="external text external">(verify)</a></span></span></td></tr></tbody></table>

<p>The most common side effects with temozolomide are nausea (feeling sick), vomiting, constipation, loss of appetite, alopecia (hair loss), headache, fatigue (tiredness), convulsions (seizures), rash, neutropenia or lymphopenia (low white-blood-cell counts), and thrombocytopenia (low blood platelet counts).<span class="mw-ref" id="cite_ref-Temodal_EPAR_4-2"><a href="#cite_note-Temodal_EPAR-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> People receiving the solution for infusion may also have injection-site reactions, such as pain, irritation, itching, warmth, swelling and redness, as well as bruising.<span class="mw-ref" id="cite_ref-Temodal_EPAR_4-3"><a href="#cite_note-Temodal_EPAR-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span></p>

<p>Temozolomide is an alkylating agent used as a treatment of some brain cancers; as a second-line treatment for astrocytoma and a first-line treatment for glioblastoma multiforme.<span class="mw-ref" id="cite_ref-Temodar_FDA_label_3-2"><a href="#cite_note-Temodar_FDA_label-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span><span class="mw-ref" id="cite_ref-NICE_5-0"><a href="#cite_note-NICE-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span><span class="mw-ref" id="cite_ref-6"><a href="#cite_note-6" style="counter-reset: mw-Ref 6;"><span class="mw-reflink-text">[6]</span></a></span> Olaparib in combination with temozolomide demonstrated substantial clinical activity in relapsed small cell lung cancer.<span class="mw-ref" id="cite_ref-7"><a href="#cite_note-7" style="counter-reset: mw-Ref 7;"><span class="mw-reflink-text">[7]</span></a></span></p>


</div><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Medical_uses">Medical uses</h2></summary>
    
<p>In the United States temozolomide is indicated for the treatment of adults with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment;<span class="mw-ref" id="cite_ref-Temodar_FDA_label_3-3"><a href="#cite_note-Temodar_FDA_label-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span> or adults with refractory anaplastic astrocytoma who have experienced disease progression on a drug regimen containing nitrosourea and <a href="Procarbazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Procarbazine" title="Procarbazine">procarbazine</a>.<span class="mw-ref" id="cite_ref-Temodar_FDA_label_3-4"><a href="#cite_note-Temodar_FDA_label-3" style="counter-reset: mw-Ref 3;"><span class="mw-reflink-text">[3]</span></a></span></p>

<p>In the European Union temozolomide is indicated for adults with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and subsequently as monotherapy treatment;<span class="mw-ref" id="cite_ref-Temodal_EPAR_4-4"><a href="#cite_note-Temodal_EPAR-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-NICE_5-1"><a href="#cite_note-NICE-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span> or children from the age of three years, adolescents and adults with malignant glioma, such as glioblastoma multiforme or anaplastic astrocytoma, showing recurrence or progression after standard therapy.<span class="mw-ref" id="cite_ref-Temodal_EPAR_4-5"><a href="#cite_note-Temodal_EPAR-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span><span class="mw-ref" id="cite_ref-NICE_5-2"><a href="#cite_note-NICE-5" style="counter-reset: mw-Ref 5;"><span class="mw-reflink-text">[5]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Contraindications">Contraindications</h2></summary>
    
<p>Temozolomide is contraindicated in people with hypersensitivity to it or to the similar drug <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Dacarbazine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Dacarbazine'" tppabs="https://ptable.com/wiki/compounds/A/Dacarbazine" title="Dacarbazine">dacarbazine</a>. The use of temozolomide is not recommended in people with severe myelosuppression.<span class="mw-ref" id="cite_ref-AC_8-0"><a href="#cite_note-AC-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Adverse_effects">Adverse effects</h2></summary>
    
<p>The most common side effect is bone marrow suppression. The most common non-hematological adverse effects associated with temozolomide are nausea and vomiting, which are either self-limiting or readily controlled with standard antiemetic therapy. These latter effects are usually mild to moderate (grade 1 to 2). The incidence of severe nausea and vomiting is around 4% each. Patients who have pre-existing or a history of severe vomiting may require antiemetic therapy before initiating temozolomide treatment. Temozolomide should be administered in the fasting state, at least one hour before a meal. Antiemetic therapy may be administered before, or following, administration of temozolomide.</p>

<p>Temozolomide is genotoxic, teratogenic and fetotoxic and should not be used during pregnancy.
Lactating women should discontinue nursing while receiving the drug because of the risk of secretion into breast milk.
One study indicated that women that have taken temozolomide without concomitant fertility preservation measures achieve pregnancy to a lesser rate later in life, but the study was too small to show statistical significance in the hypothesis that temozolomide would confer a risk of female infertility.<span class="mw-ref" id="cite_ref-9"><a href="#cite_note-9" style="counter-reset: mw-Ref 9;"><span class="mw-reflink-text">[9]</span></a></span>
In male patients, temozolomide can have genotoxic effects. Men are advised not to father a child during or up to six months after treatment and to seek advice on cryoconservation of sperm prior to treatment, because of the possibility of irreversible infertility due to temozolomide therapy.</p>

<p>Very rarely temozolomide can cause acute respiratory failure or liver damage.</p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Interactions">Interactions</h2></summary>
    
<p>As temozolomide is not metabolized in the liver and has a low affinity to plasma proteins, it is expected to have a low potential for interactions. An analysis of patient data showed no interactions with a range of other drugs; the exception is <a href="Valproic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Valproic_acid" title="Valproic acid" class="mw-redirect">valproic acid</a>, which slightly slows down temozolomide elimination from the body. Combining the drug with other myelosuppressants may increase the risk of myelosuppression.<span class="mw-ref" id="cite_ref-AC_8-1"><a href="#cite_note-AC-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Pharmacology">Pharmacology</h2></summary>
    

    <details data-level="3" open="">
    <summary class="section-heading"><h3 id="Mechanism_of_action">Mechanism of action</h3></summary>
    
<p>The therapeutic benefit of temozolomide depends on its ability to alkylate/methylate DNA, which most often occurs at the N-7 or O-6 positions of <a href="Guanine.htm" tppabs="https://ptable.com/wiki/compounds/A/Guanine" title="Guanine">guanine</a> residues. This methylation damages the DNA and triggers the death of tumor cells. However, some tumor cells are able to repair this type of DNA damage, and therefore diminish the therapeutic efficacy of temozolomide, by expressing a protein <i>O</i><sup>6</sup>-alkylguanine DNA alkyltransferase (AGT) encoded in humans by the <i>O</i>-6-methylguanine-DNA methyltransferase (<i>MGMT</i>) gene.<span class="mw-ref" id="cite_ref-10"><a href="#cite_note-10" style="counter-reset: mw-Ref 10;"><span class="mw-reflink-text">[10]</span></a></span> In some tumors, epigenetic silencing of the <i>MGMT</i> gene prevents the synthesis of this enzyme, and as a consequence such tumors are more sensitive to killing by temozolomide.<span class="mw-ref" id="cite_ref-11"><a href="#cite_note-11" style="counter-reset: mw-Ref 11;"><span class="mw-reflink-text">[11]</span></a></span> Conversely, the presence of AGT protein in brain tumors predicts poor response to temozolomide and these patients receive little benefit from chemotherapy with temozolomide.<span class="mw-ref" id="cite_ref-12"><a href="#cite_note-12" style="counter-reset: mw-Ref 12;"><span class="mw-reflink-text">[12]</span></a></span></p>


</details>
<details data-level="3" open="">
    <summary class="section-heading"><h3 id="Pharmacokinetics">Pharmacokinetics</h3></summary>
    
<p>Temozolomide is quickly and almost completely absorbed from the gut, and readily penetrates the blood–brain barrier; the concentration in the cerebrospinal fluid is 30% of the concentration in the blood plasma. Intake with food decreases maximal plasma concentrations by 33% and the area under the curve by 9%. Only 15% (10–20%) of the substance are bound to blood plasma proteins. Temozolomide is a prodrug; it is spontaneously hydrolyzed at physiological pH to 3-methyl-(triazen-1-yl)imidazole-4-carboxamide (MTIC). MTIC splits into <a href="Monomethylhydrazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Monomethylhydrazine" title="Monomethylhydrazine">monomethylhydrazine</a>, probably the active methylating agent, and 5-aminoimidazole-4-carboxamide (AIC). Other metabolites include temozolomide acid and unidentified hydrophilic substances.<span class="mw-ref" id="cite_ref-AC_8-2"><a href="#cite_note-AC-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>

<p>Plasma half-life is 1.8 hours. The substance and its metabolites are mainly excreted via the urine.<span class="mw-ref" id="cite_ref-AC_8-3"><a href="#cite_note-AC-8" style="counter-reset: mw-Ref 8;"><span class="mw-reflink-text">[8]</span></a></span></p>

<ul class="gallery mw-gallery-traditional">
<li class="gallerybox" style="width: 155px;"><div class="thumb" style="width: 150px; height: 150px;"><figure-inline><img src="../I/m/MTIC_skeletal.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/MTIC_skeletal.svg.png" data-file-width="512" data-file-height="450" data-file-type="drawing" height="105" width="120"></figure-inline></div><div class="gallerytext">MTIC, the active metabolite</div></li>
<li class="gallerybox" style="width: 155px;"><div class="thumb" style="width: 150px; height: 150px;"><figure-inline><img src="../I/m/5-aminoimidazole-4-carboxamide.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/5-aminoimidazole-4-carboxamide.svg.png" data-file-width="512" data-file-height="450" data-file-type="drawing" height="105" width="120"></figure-inline></div><div class="gallerytext">AIC (part of the naturally occurring AICA ribonucleotide)</div></li>
<li class="gallerybox" style="width: 155px;"><div class="thumb" style="width: 150px; height: 150px;"><figure-inline><img src="../I/m/Dacarbazine.svg.png" tppabs="https://ptable.com/wiki/compounds/I/m/Dacarbazine.svg.png" data-file-width="512" data-file-height="450" data-file-type="drawing" height="105" width="120"></figure-inline></div><div class="gallerytext">The related drug <a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Dacarbazine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Dacarbazine'" tppabs="https://ptable.com/wiki/compounds/A/Dacarbazine" title="Dacarbazine">dacarbazine</a><span class="mw-ref" id="cite_ref-Sansom_13-0"><a href="#cite_note-Sansom-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> for comparison</div></li>
</ul>


</details>

</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Chemical_properties">Chemical properties</h2></summary>
    
<p>Temozolomide is an imidazotetrazine derivative.<span class="mw-ref" id="cite_ref-Sansom_13-1"><a href="#cite_note-Sansom-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span> It is slightly soluble in water and aqueous acids,<span class="mw-ref" id="cite_ref-14"><a href="#cite_note-14" style="counter-reset: mw-Ref 14;"><span class="mw-reflink-text">[14]</span></a></span> and melts at <span>212</span><span>&nbsp;</span><span>°C (414</span><span>&nbsp;</span><span>°F)</span> under decomposition.<span class="mw-ref" id="cite_ref-15"><a href="#cite_note-15" style="counter-reset: mw-Ref 15;"><span class="mw-reflink-text">[15]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="History">History</h2></summary>
    
<p>The agent was developed by Malcolm Stevens and his team at Aston University in Birmingham, England.<span class="mw-ref" id="cite_ref-Sansom_13-2"><a href="#cite_note-Sansom-13" style="counter-reset: mw-Ref 13;"><span class="mw-reflink-text">[13]</span></a></span><span class="mw-ref" id="cite_ref-16"><a href="#cite_note-16" style="counter-reset: mw-Ref 16;"><span class="mw-reflink-text">[16]</span></a></span><span class="mw-ref" id="cite_ref-pmid9189180_17-0"><a href="#cite_note-pmid9189180-17" style="counter-reset: mw-Ref 17;"><span class="mw-reflink-text">[17]</span></a></span></p>

<p>It was approved for medical use in the European Union in January 1999,<span class="mw-ref" id="cite_ref-Temodal_EPAR_4-6"><a href="#cite_note-Temodal_EPAR-4" style="counter-reset: mw-Ref 4;"><span class="mw-reflink-text">[4]</span></a></span> and in the United States in August 1999.<span class="mw-ref" id="cite_ref-18"><a href="#cite_note-18" style="counter-reset: mw-Ref 18;"><span class="mw-reflink-text">[18]</span></a></span> The intravenous formulation was approved in the United States in February 2009.<span class="mw-ref" id="cite_ref-19"><a href="#cite_note-19" style="counter-reset: mw-Ref 19;"><span class="mw-reflink-text">[19]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Research">Research</h2></summary>
    
<p>Laboratory studies and clinical trials have started investigating the possibility of increasing the anticancer potency of temozolomide by combining it with other pharmacologic agents. For example, clinical trials have indicated that the addition of <a href="Chloroquine.htm" tppabs="https://ptable.com/wiki/compounds/A/Chloroquine" title="Chloroquine">chloroquine</a> might be beneficial for the treatment of glioma patients.<span class="mw-ref" id="cite_ref-20"><a href="#cite_note-20" style="counter-reset: mw-Ref 20;"><span class="mw-reflink-text">[20]</span></a></span> Laboratory studies found that temozolomide killed brain tumor cells more efficiently when <a href="Epigallocatechin_gallate.htm" tppabs="https://ptable.com/wiki/compounds/A/Epigallocatechin_gallate" title="Epigallocatechin gallate">epigallocatechin gallate</a> (<a href="Epigallocatechin_gallate.htm" tppabs="https://ptable.com/wiki/compounds/A/Epigallocatechin_gallate" title="Epigallocatechin gallate">EGCG</a>), a component of green tea, was added; however, the efficacy of this effect has not yet been confirmed in brain-tumor patients.<span class="mw-ref" id="cite_ref-21"><a href="#cite_note-21" style="counter-reset: mw-Ref 21;"><span class="mw-reflink-text">[21]</span></a></span> Preclinical studies reported in 2010 on investigations into the use of the novel oxygen diffusion-enhancing compound trans sodium crocetinate (TSC) when combined with temozolomide and radiation therapy<span class="mw-ref" id="cite_ref-22"><a href="#cite_note-22" style="counter-reset: mw-Ref 22;"><span class="mw-reflink-text">[22]</span></a></span> and a clinical trial was underway <span>as of August</span><span>&nbsp;</span><span> 2015</span>.<span class="mw-ref" id="cite_ref-23"><a href="#cite_note-23" style="counter-reset: mw-Ref 23;"><span class="mw-reflink-text">[23]</span></a></span></p>

<p>While the above-mentioned approaches have investigated whether the combination of temozolomide with other agents might improve therapeutic outcome, efforts have also started to study whether altering the temozolomide molecule itself can increase its activity. One such approach permanently fused perillyl alcohol, a natural compound with demonstrated therapeutic activity in brain cancer patients,<span class="mw-ref" id="cite_ref-24"><a href="#cite_note-24" style="counter-reset: mw-Ref 24;"><span class="mw-reflink-text">[24]</span></a></span> to the temozolomide molecule. The resultant novel compound, called NEO212 or TMZ-POH, revealed anticancer activity that was significantly greater than that of either of its two parent molecules, temozolomide and perillyl alcohol. Although <span>as of 2016</span>, NEO212 has not been tested in humans, it has shown superior cancer therapeutic activity in animal models of glioma,<span class="mw-ref" id="cite_ref-25"><a href="#cite_note-25" style="counter-reset: mw-Ref 25;"><span class="mw-reflink-text">[25]</span></a></span> melanoma,<span class="mw-ref" id="cite_ref-26"><a href="#cite_note-26" style="counter-reset: mw-Ref 26;"><span class="mw-reflink-text">[26]</span></a></span> and brain metastasis of triple-negative breast cancer.<span class="mw-ref" id="cite_ref-27"><a href="#cite_note-27" style="counter-reset: mw-Ref 27;"><span class="mw-reflink-text">[27]</span></a></span></p>

<p>Because tumor cells that express the MGMT gene are more resistant to the effects of temozolomide, researchers investigated whether the inclusion of <i>O</i><sup>6</sup>-benzylguanine (<i>O</i><sup>6</sup>-BG), an AGT inhibitor, could overcome this resistance and improve the drug's therapeutic effectiveness. In the laboratory, this combination indeed showed increased temozolomide activity in tumor-cell culture in vitro and in animal models in vivo.<span class="mw-ref" id="cite_ref-28"><a href="#cite_note-28" style="counter-reset: mw-Ref 28;"><span class="mw-reflink-text">[28]</span></a></span> However, a recently completed phase-II clinical trial with brain-tumor patients yielded mixed outcomes; while there was some improved therapeutic activity when <i>O</i><sup>6</sup>-BG and temozolomide were given to patients with temozolomide-resistant anaplastic glioma, there seemed to be no significant restoration of temozolomide sensitivity in patients with temozolomide-resistant glioblastoma multiforme.<span class="mw-ref" id="cite_ref-29"><a href="#cite_note-29" style="counter-reset: mw-Ref 29;"><span class="mw-reflink-text">[29]</span></a></span></p>

<p>Some efforts focus on engineering hematopoietic stem cells expressing the <i>MGMT</i> gene prior to transplanting them into brain-tumor patients. This would allow for the patients to receive stronger doses of temozolomide, since the patient's hematopoietic cells would be resistant to the drug.<span class="mw-ref" id="cite_ref-30"><a href="#cite_note-30" style="counter-reset: mw-Ref 30;"><span class="mw-reflink-text">[30]</span></a></span></p>

<p>High doses of temozolomide in high-grade gliomas have low toxicity, but the results are comparable to the standard doses.<span class="mw-ref" id="cite_ref-31"><a href="#cite_note-31" style="counter-reset: mw-Ref 31;"><span class="mw-reflink-text">[31]</span></a></span></p>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="References">References</h2></summary>
    
<div class="reflist " style=" list-style-type: decimal;">
<div class="mw-references-wrap mw-references-columns"><ol class="mw-references references"><li id="cite_note-1"> <span id="mw-reference-text-cite_note-1" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.drugs.com/international/temozolomide.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.drugs.com/international/temozolomide.html'" tppabs="https://www.drugs.com/international/temozolomide.html" class="external text external">"Temozolomide"</a>. <i>Drugs.com</i>. 4 May 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">7 May</span> 2020</span>.</cite></span></li><li id="cite_note-2"> <span id="mw-reference-text-cite_note-2" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.medicines.org.uk/emc/product/1463/smpc  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.medicines.org.uk/emc/product/1463/smpc'" tppabs="https://www.medicines.org.uk/emc/product/1463/smpc" class="external text external">"Temodal Capsules - Summary of Product Characteristics (SmPC)"</a>. <i>(emc)</i>. 24 October 2019<span class="reference-accessdate">. Retrieved <span class="nowrap">7 May</span> 2020</span>.</cite></span></li><li id="cite_note-Temodar_FDA_label-3"> <span id="mw-reference-text-cite_note-Temodar_FDA_label-3" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=046a9011-3911-4d3f-a15f-fbb56d5aad56  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=046a9011-3911-4d3f-a15f-fbb56d5aad56'" tppabs="https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=046a9011-3911-4d3f-a15f-fbb56d5aad56" class="external text external">"Temodar- temozolomide capsule Temodar- temozolomide injection, powder, lyophilized, for solution"</a>. <i>DailyMed</i>. 31 January 2020<span class="reference-accessdate">. Retrieved <span class="nowrap">7 May</span> 2020</span>.</cite></span></li><li id="cite_note-Temodal_EPAR-4"> <span id="mw-reference-text-cite_note-Temodal_EPAR-4" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.ema.europa.eu/en/medicines/human/EPAR/temodal  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ema.europa.eu/en/medicines/human/EPAR/temodal'" tppabs="https://www.ema.europa.eu/en/medicines/human/EPAR/temodal" class="external text external">"Temodal EPAR"</a>. <i>European Medicines Agency (EMA)</i><span class="reference-accessdate">. Retrieved <span class="nowrap">7 May</span> 2020</span>.</cite> Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.</span></li><li id="cite_note-NICE-5"> <span id="mw-reference-text-cite_note-NICE-5" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.nice.org.uk/guidance/ta23/resources/guidance-on-the-use-of-temozolomide-for-the-treatment-of-recurrent-malignant-glioma-brain-cancer-pdf-2294454507973  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nice.org.uk/guidance/ta23/resources/guidance-on-the-use-of-temozolomide-for-the-treatment-of-recurrent-malignant-glioma-brain-cancer-pdf-2294454507973'" tppabs="https://www.nice.org.uk/guidance/ta23/resources/guidance-on-the-use-of-temozolomide-for-the-treatment-of-recurrent-malignant-glioma-brain-cancer-pdf-2294454507973" class="external text external">"Guidance on the use of temozolomide for the treatment of recurrent malignant glioma (brain cancer)"</a> <span class="cs1-format">(PDF)</span>. 3 March 2016<span class="reference-accessdate">. Retrieved <span class="nowrap">7 May</span> 2020</span>. <a href="javascript:if(confirm('https://www.nice.org.uk/guidance/ta23/informationforpublic  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.nice.org.uk/guidance/ta23/informationforpublic'" tppabs="https://www.nice.org.uk/guidance/ta23/informationforpublic" class="external text external">Lay summary</a>.</cite></span></li><li id="cite_note-6"> <span id="mw-reference-text-cite_note-6" class="mw-reference-text"><cite id="CITEREFSasmitaWongLing2018" class="citation journal cs1">Sasmita AO, Wong YP, Ling AP (February 2018). <a href="javascript:if(confirm('https://doi.org/10.1111/ajco.12756  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111/ajco.12756'" tppabs="https://doi.org/10.1111/ajco.12756" class="external text external">"Biomarkers and therapeutic advances in glioblastoma multiforme"</a>. <i>Asia-Pacific Journal of Clinical Oncology</i>. <b>14</b> (1): 40–51. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1111%2Fajco.12756  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1111%2Fajco.12756'" tppabs="https://doi.org/10.1111%2Fajco.12756" class="external text external">10.1111/ajco.12756</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/28840962  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/28840962'" tppabs="https://pubmed.ncbi.nlm.nih.gov/28840962" class="external text external">28840962</a>.</cite></span></li><li id="cite_note-7"> <span id="mw-reference-text-cite_note-7" class="mw-reference-text"><cite id="CITEREFFaragoYeapStanzioneHung2019" class="citation journal cs1">Farago AF, Yeap BY, Stanzione M, Hung YP, Heist RS, Marcoux JP,  et al. (October 2019). <a href="javascript:if(confirm('https://doi.org/10.1158/2159-8290.CD-19-0582  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1158/2159-8290.CD-19-0582'" tppabs="https://doi.org/10.1158/2159-8290.CD-19-0582" class="external text external">"Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer"</a>. <i>Cancer Discov</i>. <b>9</b> (10): 1372–1387. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1158%2F2159-8290.CD-19-0582  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1158%2F2159-8290.CD-19-0582'" tppabs="https://doi.org/10.1158%2F2159-8290.CD-19-0582" class="external text external">10.1158/2159-8290.CD-19-0582</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/31416802  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/31416802'" tppabs="https://pubmed.ncbi.nlm.nih.gov/31416802" class="external text external">31416802</a>.</cite></span></li><li id="cite_note-AC-8"> <span id="mw-reference-text-cite_note-AC-8" class="mw-reference-text"><cite class="citation book cs1"><i>Austria-Codex</i> (in German). Vienna: Österreichischer Apothekerverlag. 2018. Temodal 5 mg-Hartkapseln.</cite></span></li><li id="cite_note-9"> <span id="mw-reference-text-cite_note-9" class="mw-reference-text"><cite id="CITEREFSitbon_SitrukSansonPradesLefebvre2010" class="citation journal cs1">Sitbon Sitruk L, Sanson M, Prades M, Lefebvre G, Schubert B, Poirot C (November 2010). "Chimiothérapie à gonadotoxicité inconnue et préservation de la fertilité: Exemple du témozolomide" <span>[</span>Unknown gonadotoxicity chemotherapy and preservation of fertility: example of Temozolomide<span>]</span>. <i>Gynecologie, Obstetrique &amp; Fertilite</i> (in French). <b>38</b> (11): 660–2. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.gyobfe.2010.09.002  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.gyobfe.2010.09.002'" tppabs="https://doi.org/10.1016%2Fj.gyobfe.2010.09.002" class="external text external">10.1016/j.gyobfe.2010.09.002</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/21030284  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/21030284'" tppabs="https://pubmed.ncbi.nlm.nih.gov/21030284" class="external text external">21030284</a>.</cite></span></li><li id="cite_note-10"> <span id="mw-reference-text-cite_note-10" class="mw-reference-text"><cite id="CITEREFJacintoEsteller2007" class="citation journal cs1">Jacinto FV, Esteller M (August 2007). "MGMT hypermethylation: a prognostic foe, a predictive friend". <i>DNA Repair</i>. <b>6</b> (8): 1155–60. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.dnarep.2007.03.013  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.dnarep.2007.03.013'" tppabs="https://doi.org/10.1016%2Fj.dnarep.2007.03.013" class="external text external">10.1016/j.dnarep.2007.03.013</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17482895  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17482895'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17482895" class="external text external">17482895</a>.</cite></span></li><li id="cite_note-11"> <span id="mw-reference-text-cite_note-11" class="mw-reference-text"><cite id="CITEREFHegiDiserensGorliaHamou2005" class="citation journal cs1">Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, Kros JM, Hainfellner JA, Mason W, Mariani L, Bromberg JE, Hau P, Mirimanoff RO, Cairncross JG, Janzer RC, Stupp R (March 2005). <a href="javascript:if(confirm('https://serval.unil.ch/resource/serval:BIB_59DF1F31757A.P001/REF.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://serval.unil.ch/resource/serval:BIB_59DF1F31757A.P001/REF.pdf'" tppabs="https://serval.unil.ch/resource/serval:BIB_59DF1F31757A.P001/REF.pdf" class="external text external">"MGMT gene silencing and benefit from temozolomide in glioblastoma"</a> <span class="cs1-format">(PDF)</span>. <i>The New England Journal of Medicine</i>. <b>352</b> (10): 997–1003. doi:<a href="javascript:if(confirm('https://doi.org/10.1056%2FNEJMoa043331  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1056%2FNEJMoa043331'" tppabs="https://doi.org/10.1056%2FNEJMoa043331" class="external text external">10.1056/NEJMoa043331</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/15758010  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/15758010'" tppabs="https://pubmed.ncbi.nlm.nih.gov/15758010" class="external text external">15758010</a>.</cite></span></li><li id="cite_note-12"> <span id="mw-reference-text-cite_note-12" class="mw-reference-text"><cite id="CITEREFStuppHegiMasonvan_den_Bent2009" class="citation journal cs1">Stupp R, Hegi ME, Mason WP, van den Bent MJ, Taphoorn MJ, Janzer RC, Ludwin SK, Allgeier A, Fisher B, Belanger K, Hau P, Brandes AA, Gijtenbeek J, Marosi C, Vecht CJ, Mokhtari K, Wesseling P, Villa S, Eisenhauer E, Gorlia T, Weller M, Lacombe D, Cairncross JG, Mirimanoff RO, European Organisation for Research Treatment of Cancer Brain Tumour Radiation Oncology Groups, National Cancer Institute of Canada Clinical Trials Group) (May 2009). "Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial". <i>The Lancet. Oncology</i>. <b>10</b> (5): 459–66. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS1470-2045%2809%2970025-7  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS1470-2045%2809%2970025-7'" tppabs="https://doi.org/10.1016%2FS1470-2045%2809%2970025-7" class="external text external">10.1016/S1470-2045(09)70025-7</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19269895  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19269895'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19269895" class="external text external">19269895</a>.</cite></span></li><li id="cite_note-Sansom-13"> <span id="mw-reference-text-cite_note-Sansom-13" class="mw-reference-text"><cite id="CITEREFSansom2009" class="citation journal cs1">Sansom C (July 2009). <a href="javascript:if(confirm('http://www.rsc.org/images/TEMOZOLOMIDE_ChemistryWorldJul09_tcm18-155909.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://www.rsc.org/images/TEMOZOLOMIDE_ChemistryWorldJul09_tcm18-155909.pdf'" tppabs="http://www.rsc.org/images/TEMOZOLOMIDE_ChemistryWorldJul09_tcm18-155909.pdf" class="external text external">"Temozolomide – birth of a blockbuster"</a> <span class="cs1-format">(PDF)</span>. <i>Chemistry World</i>: 48–51.</cite></span></li><li id="cite_note-14"> <span id="mw-reference-text-cite_note-14" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.ema.europa.eu/documents/scientific-discussion/temodal-epar-scientific-discussion_en.pdf  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ema.europa.eu/documents/scientific-discussion/temodal-epar-scientific-discussion_en.pdf'" tppabs="https://www.ema.europa.eu/documents/scientific-discussion/temodal-epar-scientific-discussion_en.pdf" class="external text external">"Temodal: EPAR – Scientific Discussion"</a> <span class="cs1-format">(PDF)</span>. European Medicines Agency. 2005-12-13.</cite></span></li><li id="cite_note-15"> <span id="mw-reference-text-cite_note-15" class="mw-reference-text"><cite id="CITEREFDinnendahl,_VFricke,_U2016" class="citation book cs1">Dinnendahl, V; Fricke, U, eds. (2016). <i>Arzneistoff-Profile</i> (in German). <b>9</b> (29 ed.). Eschborn, Germany: Govi Pharmazeutischer Verlag. ISBN<span>&nbsp;</span><bdi>978-3-7741-9846-3</bdi>.</cite></span></li><li id="cite_note-16"> <span id="mw-reference-text-cite_note-16" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://web.archive.org/web/20120314043035/http://info.cancerresearchuk.org/cancerandresearch/progress/cancer_drugs/drug_discovery/temozolomide/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://web.archive.org/web/20120314043035/http://info.cancerresearchuk.org/cancerandresearch/progress/cancer_drugs/drug_discovery/temozolomide/'" tppabs="https://web.archive.org/web/20120314043035/http://info.cancerresearchuk.org/cancerandresearch/progress/cancer_drugs/drug_discovery/temozolomide/" class="external text external">"Malcolm Steven – interview"</a>. <i>Cancer Research UK impact &amp; achievements page</i>. 2013-08-22. Archived from <a href="javascript:if(confirm('http://info.cancerresearchuk.org/cancerandresearch/progress/cancer_drugs/drug_discovery/temozolomide/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://info.cancerresearchuk.org/cancerandresearch/progress/cancer_drugs/drug_discovery/temozolomide/'" tppabs="http://info.cancerresearchuk.org/cancerandresearch/progress/cancer_drugs/drug_discovery/temozolomide/" class="external text external">the original</a> on 14 March 2012.</cite></span></li><li id="cite_note-pmid9189180-17"> <span id="mw-reference-text-cite_note-pmid9189180-17" class="mw-reference-text"><cite id="CITEREFNewlandsStevensWedgeWheelhouse1997" class="citation journal cs1">Newlands ES, Stevens MF, Wedge SR, Wheelhouse RT, Brock C (January 1997). "Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials". <i>Cancer Treatment Reviews</i>. <b>23</b> (1): 35–61. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2FS0305-7372%2897%2990019-0  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2FS0305-7372%2897%2990019-0'" tppabs="https://doi.org/10.1016%2FS0305-7372%2897%2990019-0" class="external text external">10.1016/S0305-7372(97)90019-0</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/9189180  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/9189180'" tppabs="https://pubmed.ncbi.nlm.nih.gov/9189180" class="external text external">9189180</a>.</cite></span></li><li id="cite_note-18"> <span id="mw-reference-text-cite_note-18" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/21029_Temodar.cfm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/21029_Temodar.cfm'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/nda/99/21029_Temodar.cfm" class="external text external">"Drug Approval Package: Temodar (Temozolomide) NDA# 021029"</a>. <i>U.S. Food and Drug Administration (FDA)</i>. 30 March 2001<span class="reference-accessdate">. Retrieved <span class="nowrap">7 May</span> 2020</span>.</cite></span></li><li id="cite_note-19"> <span id="mw-reference-text-cite_note-19" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022277_temodar_toc.cfm  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022277_temodar_toc.cfm'" tppabs="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2009/022277_temodar_toc.cfm" class="external text external">"Drug Approval Package: Temodar NDA #022277"</a>. <i>U.S. Food and Drug Administration (FDA)</i>. 24 November 2009<span class="reference-accessdate">. Retrieved <span class="nowrap">7 May</span> 2020</span>.</cite></span></li><li id="cite_note-20"> <span id="mw-reference-text-cite_note-20" class="mw-reference-text"><cite id="CITEREFGilbert2006" class="citation journal cs1">Gilbert MR (March 2006). "New treatments for malignant gliomas: careful evaluation and cautious optimism required". <i>Annals of Internal Medicine</i>. <b>144</b> (5): 371–3. doi:<a href="javascript:if(confirm('https://doi.org/10.7326%2F0003-4819-144-5-200603070-00015  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.7326%2F0003-4819-144-5-200603070-00015'" tppabs="https://doi.org/10.7326%2F0003-4819-144-5-200603070-00015" class="external text external">10.7326/0003-4819-144-5-200603070-00015</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16520480  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16520480'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16520480" class="external text external">16520480</a>.</cite></span></li><li id="cite_note-21"> <span id="mw-reference-text-cite_note-21" class="mw-reference-text"><cite id="CITEREFPyrkoSchönthalHofmanChen2007" class="citation journal cs1">Pyrko P, Schönthal AH, Hofman FM, Chen TC, Lee AS (October 2007). <a href="javascript:if(confirm('http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=17942911  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=17942911'" tppabs="http://cancerres.aacrjournals.org/cgi/pmidlookup?view=long&pmid=17942911" class="external text external">"The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas"</a>. <i>Cancer Research</i>. <b>67</b> (20): 9809–16. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1158%2F0008-5472.CAN-07-0625  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1158%2F0008-5472.CAN-07-0625'" tppabs="https://doi.org/10.1158%2F0008-5472.CAN-07-0625" class="external text external">10.1158/0008-5472.CAN-07-0625</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17942911  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17942911'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17942911" class="external text external">17942911</a>.</cite></span></li><li id="cite_note-22"> <span id="mw-reference-text-cite_note-22" class="mw-reference-text"><cite id="CITEREFSheehanCifarelliDassoulasOlson2010" class="citation journal cs1">Sheehan J, Cifarelli CP, Dassoulas K, Olson C, Rainey J, Han S (August 2010). "Trans-sodium crocetinate enhancing survival and glioma response on magnetic resonance imaging to radiation and temozolomide". <i>Journal of Neurosurgery</i>. <b>113</b> (2): 234–9. doi:<a href="javascript:if(confirm('https://doi.org/10.3171%2F2009.11.JNS091314  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.3171%2F2009.11.JNS091314'" tppabs="https://doi.org/10.3171%2F2009.11.JNS091314" class="external text external">10.3171/2009.11.JNS091314</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/20001586  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/20001586'" tppabs="https://pubmed.ncbi.nlm.nih.gov/20001586" class="external text external">20001586</a>.</cite></span></li><li id="cite_note-23"> <span id="mw-reference-text-cite_note-23" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('http://clinicaltrials.gov/ct2/show/NCT01465347?term=tsc&rank=4  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://clinicaltrials.gov/ct2/show/NCT01465347?term=tsc&rank=4'" tppabs="http://clinicaltrials.gov/ct2/show/NCT01465347?term=tsc&rank=4" class="external text external">"Safety and Efficacy Study of Trans Sodium Crocetinate (TSC) With Concomitant Radiation Therapy and Temozolomide in Newly Diagnosed Glioblastoma (GBM)"</a>. ClinicalTrials.gov. November 2011<span class="reference-accessdate">. Retrieved <span class="nowrap">2016-02-01</span></span>.</cite></span></li><li id="cite_note-24"> <span id="mw-reference-text-cite_note-24" class="mw-reference-text"><cite id="CITEREFDa_FonsecaTeixeiraSilvaDe_Saldanha_Da_Gama_Fischer2013" class="citation journal cs1">Da Fonseca CO, Teixeira RM, Silva JC, De Saldanha Da Gama Fischer J, Meirelles OC, Landeiro JA, Quirico-Santos T (December 2013). "Long-term outcome in patients with recurrent malignant glioma treated with Perillyl alcohol inhalation". <i>Anticancer Research</i>. <b>33</b> (12): 5625–31. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24324108  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24324108'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24324108" class="external text external">24324108</a>.</cite></span></li><li id="cite_note-25"> <span id="mw-reference-text-cite_note-25" class="mw-reference-text"><cite id="CITEREFChoWangJhaveriLee2014" class="citation journal cs1">Cho HY, Wang W, Jhaveri N, Lee DJ, Sharma N, Dubeau L, Schönthal AH, Hofman FM, Chen TC (August 2014). <a href="javascript:if(confirm('https://doi.org/10.1158/1535-7163.mct-13-0964  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1158/1535-7163.mct-13-0964'" tppabs="https://doi.org/10.1158/1535-7163.mct-13-0964" class="external text external">"NEO212, temozolomide conjugated to perillyl alcohol, is a novel drug for effective treatment of a broad range of temozolomide-resistant gliomas"</a>. <i>Molecular Cancer Therapeutics</i>. <b>13</b> (8): 2004–17. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1158%2F1535-7163.mct-13-0964  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1158%2F1535-7163.mct-13-0964'" tppabs="https://doi.org/10.1158%2F1535-7163.mct-13-0964" class="external text external">10.1158/1535-7163.mct-13-0964</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24994771  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24994771'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24994771" class="external text external">24994771</a>.</cite></span></li><li id="cite_note-26"> <span id="mw-reference-text-cite_note-26" class="mw-reference-text"><cite id="CITEREFChenChoWangNguyen2015" class="citation journal cs1">Chen TC, Cho HY, Wang W, Nguyen J, Jhaveri N, Rosenstein-Sisson R, Hofman FM, Schönthal AH (March 2015). "A novel temozolomide analog, NEO212, with enhanced activity against MGMT-positive melanoma in vitro and in vivo". <i>Cancer Letters</i>. <b>358</b> (2): 144–51. doi:<a href="javascript:if(confirm('https://doi.org/10.1016%2Fj.canlet.2014.12.021  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1016%2Fj.canlet.2014.12.021'" tppabs="https://doi.org/10.1016%2Fj.canlet.2014.12.021" class="external text external">10.1016/j.canlet.2014.12.021</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/25524552  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/25524552'" tppabs="https://pubmed.ncbi.nlm.nih.gov/25524552" class="external text external">25524552</a>.</cite></span></li><li id="cite_note-27"> <span id="mw-reference-text-cite_note-27" class="mw-reference-text"><cite id="CITEREFChenChoWangBarath2014" class="citation journal cs1">Chen TC, Cho HY, Wang W, Barath M, Sharma N, Hofman FM, Schönthal AH (May 2014). <a href="javascript:if(confirm('https://doi.org/10.1158/1535-7163.mct-13-0882  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1158/1535-7163.mct-13-0882'" tppabs="https://doi.org/10.1158/1535-7163.mct-13-0882" class="external text external">"A novel temozolomide-perillyl alcohol conjugate exhibits superior activity against breast cancer cells in vitro and intracranial triple-negative tumor growth in vivo"</a>. <i>Molecular Cancer Therapeutics</i>. <b>13</b> (5): 1181–93. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1158%2F1535-7163.mct-13-0882  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1158%2F1535-7163.mct-13-0882'" tppabs="https://doi.org/10.1158%2F1535-7163.mct-13-0882" class="external text external">10.1158/1535-7163.mct-13-0882</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/24623736  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/24623736'" tppabs="https://pubmed.ncbi.nlm.nih.gov/24623736" class="external text external">24623736</a>.</cite></span></li><li id="cite_note-28"> <span id="mw-reference-text-cite_note-28" class="mw-reference-text"><cite id="CITEREFUenoKoGrubbsYoshimoto2006" class="citation journal cs1">Ueno T, Ko SH, Grubbs E, Yoshimoto Y, Augustine C, Abdel-Wahab Z, Cheng TY, Abdel-Wahab OI, Pruitt SK, Friedman HS, Tyler DS (March 2006). <a href="javascript:if(confirm('http://mct.aacrjournals.org/cgi/pmidlookup?view=long&pmid=16546988  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='http://mct.aacrjournals.org/cgi/pmidlookup?view=long&pmid=16546988'" tppabs="http://mct.aacrjournals.org/cgi/pmidlookup?view=long&pmid=16546988" class="external text external">"Modulation of chemotherapy resistance in regional therapy: a novel therapeutic approach to advanced extremity melanoma using intra-arterial temozolomide in combination with systemic O6-benzylguanine"</a>. <i>Molecular Cancer Therapeutics</i>. <b>5</b> (3): 732–8. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1158%2F1535-7163.MCT-05-0098  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1158%2F1535-7163.MCT-05-0098'" tppabs="https://doi.org/10.1158%2F1535-7163.MCT-05-0098" class="external text external">10.1158/1535-7163.MCT-05-0098</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/16546988  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/16546988'" tppabs="https://pubmed.ncbi.nlm.nih.gov/16546988" class="external text external">16546988</a>.</cite></span></li><li id="cite_note-29"> <span id="mw-reference-text-cite_note-29" class="mw-reference-text"><cite id="CITEREFQuinnJiangReardonDesjardins2009" class="citation journal cs1">Quinn JA, Jiang SX, Reardon DA, Desjardins A, Vredenburgh JJ, Rich JN, Gururangan S, Friedman AH, Bigner DD, Sampson JH, McLendon RE, Herndon JE, Walker A, Friedman HS (March 2009). <a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2667825  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2667825'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2667825" class="external text external">"Phase II trial of temozolomide plus o6-benzylguanine in adults with recurrent, temozolomide-resistant malignant glioma"</a>. <i>Journal of Clinical Oncology</i>. <b>27</b> (8): 1262–7. doi:<a href="javascript:if(confirm('https://doi.org/10.1200%2FJCO.2008.18.8417  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1200%2FJCO.2008.18.8417'" tppabs="https://doi.org/10.1200%2FJCO.2008.18.8417" class="external text external">10.1200/JCO.2008.18.8417</a>. PMC<span>&nbsp;</span><span class="cs1-lock-free"><a href="javascript:if(confirm('https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2667825  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2667825'" tppabs="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2667825" class="external text external">2667825</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/19204199  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/19204199'" tppabs="https://pubmed.ncbi.nlm.nih.gov/19204199" class="external text external">19204199</a>.</cite></span></li><li id="cite_note-30"> <span id="mw-reference-text-cite_note-30" class="mw-reference-text"><cite class="citation web cs1"><a href="javascript:if(confirm('https://www.fredhutch.org/en/news/center-news/2011/05/marrow-cells-chemotherapy.html  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.fredhutch.org/en/news/center-news/2011/05/marrow-cells-chemotherapy.html'" tppabs="https://www.fredhutch.org/en/news/center-news/2011/05/marrow-cells-chemotherapy.html" class="external text external">"Investigative Engineered Bone Marrow Cell Therapy"</a>. Fred Hutchinson Cancer Research Center. 2011-05-23.</cite></span></li><li id="cite_note-31"> <span id="mw-reference-text-cite_note-31" class="mw-reference-text"><cite id="CITEREFDall'oglioD'AmicoPioliGabbani2008" class="citation journal cs1">Dall'oglio S, D'Amico A, Pioli F, Gabbani M, Pasini F, Passarin MG, Talacchi A, Turazzi S, Maluta S (December 2008). "Dose-intensity temozolomide after concurrent chemoradiotherapy in operated high-grade gliomas". <i>Journal of Neuro-Oncology</i>. <b>90</b> (3): 315–9. doi:<a href="javascript:if(confirm('https://doi.org/10.1007%2Fs11060-008-9663-9  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1007%2Fs11060-008-9663-9'" tppabs="https://doi.org/10.1007%2Fs11060-008-9663-9" class="external text external">10.1007/s11060-008-9663-9</a>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/18688571  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/18688571'" tppabs="https://pubmed.ncbi.nlm.nih.gov/18688571" class="external text external">18688571</a>.</cite></span></li></ol></div></div>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="Further_reading">Further reading</h2></summary>
    
<ul><li><cite id="CITEREFKaloshiBenouaich-AmielDiakiteTaillibert2007" class="citation journal cs1">Kaloshi G, Benouaich-Amiel A, Diakite F,  et al. (May 2007). <a href="javascript:if(confirm('https://doi.org/10.1212/01.wnl.0000262034.26310.a2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1212/01.wnl.0000262034.26310.a2'" tppabs="https://doi.org/10.1212/01.wnl.0000262034.26310.a2" class="external text external">"Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome"</a>. <i>Neurology</i>. <b>68</b> (21): 1831–6. doi:<span class="cs1-lock-free"><a href="javascript:if(confirm('https://doi.org/10.1212%2F01.wnl.0000262034.26310.a2  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://doi.org/10.1212%2F01.wnl.0000262034.26310.a2'" tppabs="https://doi.org/10.1212%2F01.wnl.0000262034.26310.a2" class="external text external">10.1212/01.wnl.0000262034.26310.a2</a></span>. PMID<span>&nbsp;</span><a href="javascript:if(confirm('https://pubmed.ncbi.nlm.nih.gov/17515545  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://pubmed.ncbi.nlm.nih.gov/17515545'" tppabs="https://pubmed.ncbi.nlm.nih.gov/17515545" class="external text external">17515545</a>. <a href="javascript:if(confirm('https://www.aan.com/PressRoom/Home/PressRelease/509  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://www.aan.com/PressRoom/Home/PressRelease/509'" tppabs="https://www.aan.com/PressRoom/Home/PressRelease/509" class="external text external">Lay summary</a>.</cite></li></ul>


    
</details><details data-level="2" open="">
    <summary class="section-heading"><h2 id="External_links">External links</h2></summary>
    
<ul><li><cite class="citation web cs1"><a href="javascript:if(confirm('https://druginfo.nlm.nih.gov/drugportal/name/temozolomide  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://druginfo.nlm.nih.gov/drugportal/name/temozolomide'" tppabs="https://druginfo.nlm.nih.gov/drugportal/name/temozolomide" class="external text external">"Temozolomide"</a>. <i>Drug Information Portal</i>. U.S. National Library of Medicine.</cite></li>
<li><cite class="citation web cs1"><a href="javascript:if(confirm('https://about-cancer.cancerresearchuk.org/about-cancer/cancer-in-general/treatment/cancer-drugs/drugs/temozolomide  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://about-cancer.cancerresearchuk.org/about-cancer/cancer-in-general/treatment/cancer-drugs/drugs/temozolomide'" tppabs="https://about-cancer.cancerresearchuk.org/about-cancer/cancer-in-general/treatment/cancer-drugs/drugs/temozolomide" class="external text external">"Temozolomide (Temodal)"</a>. <i>Cancer Research UK</i>.</cite></li></ul>

<div role="navigation" class="navbox" aria-labelledby="Merck_&amp;amp;_Co." style="padding:3px"><table class="nowraplinks mw-collapsible autocollapse navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Merck_&amp;amp;_Co." style="font-size:114%;margin:0 4em">Merck &amp; Co.</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">Subsidiaries</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Cubist Pharmaceuticals</li>
<li>H. K. Mulford Company</li>
<li>Schering-Plough</li>
<li>Viralytics</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Schering-Plough</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Coppertone sign</li>
<li><a href="Desloratadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Desloratadine" title="Desloratadine">Desloratadine</a></li>
<li><a href="Ezetimibe.htm" tppabs="https://ptable.com/wiki/compounds/A/Ezetimibe" title="Ezetimibe">Ezetimibe</a></li>
<li>Ezetimibe/simvastatin</li>
<li><a href="Famciclovir.htm" tppabs="https://ptable.com/wiki/compounds/A/Famciclovir" title="Famciclovir">Famciclovir</a></li>
<li><a href="Infliximab.htm" tppabs="https://ptable.com/wiki/compounds/A/Infliximab" title="Infliximab">Infliximab</a></li>
<li><a href="Loratadine.htm" tppabs="https://ptable.com/wiki/compounds/A/Loratadine" title="Loratadine">Loratadine</a></li>
<li>Mometasone</li>
<li><a href="Rocuronium_bromide.htm" tppabs="https://ptable.com/wiki/compounds/A/Rocuronium_bromide" title="Rocuronium bromide">Rocuronium bromide</a></li>
<li><a href="Temozolomide.htm" tppabs="https://ptable.com/wiki/compounds/A/Temozolomide" title="Temozolomide">Temozolomide</a></li>
<li>Tibolone</li>
<li><a href="Urofollitropin.htm" tppabs="https://ptable.com/wiki/compounds/A/Urofollitropin" title="Urofollitropin">Urofollitropin</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Facilities</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Merck Headquarters Building</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Publications</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Merck Manual of Diagnosis and Therapy</li>
<li>The Merck Manuals</li></ul>
</div></td></tr></tbody></table></div>
<div role="navigation" class="navbox" aria-labelledby="Intracellular_chemotherapeutic_agents_/_antineoplastic_agents_(L01)" style="padding:3px"><table class="nowraplinks mw-collapsible mw-collapsed navbox-inner" style="border-spacing:0;background:transparent;color:inherit"><tbody><tr><th scope="col" class="navbox-title" colspan="2"><div id="Intracellular_chemotherapeutic_agents_/_antineoplastic_agents_(L01)" style="font-size:114%;margin:0 4em">Intracellular chemotherapeutic agents<span>&nbsp;</span>/ antineoplastic agents (L01)</div></th></tr><tr><th scope="row" class="navbox-group" style="width:1%">SPs/MIs<br>(M phase)</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Block microtubule assembly</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Vinca alkaloids</i> (<a href="Vinblastine.htm" tppabs="https://ptable.com/wiki/compounds/A/Vinblastine" title="Vinblastine">Vinblastine</a><sup>#</sup></li>
<li><a href="Vincristine.htm" tppabs="https://ptable.com/wiki/compounds/A/Vincristine" title="Vincristine">Vincristine</a><sup>#</sup></li>
<li><a href="Vindesine.htm" tppabs="https://ptable.com/wiki/compounds/A/Vindesine" title="Vindesine">Vindesine</a></li>
<li>Vinflunine<sup>§</sup></li>
<li><a href="Vinorelbine.htm" tppabs="https://ptable.com/wiki/compounds/A/Vinorelbine" title="Vinorelbine">Vinorelbine</a><sup>#</sup>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Block microtubule disassembly</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Taxanes</i> (Cabazitaxel</li>
<li><a href="Docetaxel.htm" tppabs="https://ptable.com/wiki/compounds/A/Docetaxel" title="Docetaxel">Docetaxel</a><sup>#</sup></li>
<li>Larotaxel</li>
<li>Ortataxel<sup>†</sup></li>
<li><a href="Paclitaxel.htm" tppabs="https://ptable.com/wiki/compounds/A/Paclitaxel" title="Paclitaxel">Paclitaxel</a><sup>#</sup></li>
<li>Tesetaxel)</li>
<li><i>Epothilones</i> (Ixabepilone)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">DNA replication<br>inhibitor</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">DNA precursors/<br>antimetabolites<br>(S phase)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Folic acid</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Dihydrofolate reductase inhibitor</i> (<a href="Aminopterin.htm" tppabs="https://ptable.com/wiki/compounds/A/Aminopterin" title="Aminopterin">Aminopterin</a></li>
<li><a href="Methotrexate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methotrexate" title="Methotrexate">Methotrexate</a><sup>#</sup></li>
<li><a href="Pemetrexed.htm" tppabs="https://ptable.com/wiki/compounds/A/Pemetrexed" title="Pemetrexed">Pemetrexed</a></li>
<li>Pralatrexate)</li>
<li><i>Thymidylate synthase inhibitor</i> (<a href="Pemetrexed.htm" tppabs="https://ptable.com/wiki/compounds/A/Pemetrexed" title="Pemetrexed">Pemetrexed</a></li>
<li><a href="Raltitrexed.htm" tppabs="https://ptable.com/wiki/compounds/A/Raltitrexed" title="Raltitrexed">Raltitrexed</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Purine</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Adenosine deaminase inhibitor</i> (<a href="Pentostatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Pentostatin" title="Pentostatin">Pentostatin</a>)</li></ul>

<ul><li><i>Halogenated/ribonucleotide reductase inhibitors</i> (<a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Cladribine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Cladribine'" tppabs="https://ptable.com/wiki/compounds/A/Cladribine" title="Cladribine">Cladribine</a></li>
<li><a href="Clofarabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Clofarabine" title="Clofarabine">Clofarabine</a></li>
<li><a href="Fludarabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fludarabine" title="Fludarabine">Fludarabine</a>)</li>
<li><a href="Nelarabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Nelarabine" title="Nelarabine">Nelarabine</a></li></ul>

<ul><li><i>Thiopurine</i> (<a href="Mercaptopurine.htm" tppabs="https://ptable.com/wiki/compounds/A/Mercaptopurine" title="Mercaptopurine">Mercaptopurine</a><sup>#</sup></li>
<li><a href="Tioguanine.htm" tppabs="https://ptable.com/wiki/compounds/A/Tioguanine" title="Tioguanine">Tioguanine</a><sup>#</sup>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Pyrimidine</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Thymidylate synthase inhibitor</i> (<a href="Capecitabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Capecitabine" title="Capecitabine">Capecitabine</a><sup>#</sup></li>
<li><a href="Carmofur.htm" tppabs="https://ptable.com/wiki/compounds/A/Carmofur" title="Carmofur">Carmofur</a></li>
<li>Doxifluridine</li>
<li><a href="Floxuridine.htm" tppabs="https://ptable.com/wiki/compounds/A/Floxuridine" title="Floxuridine">Floxuridine</a></li>
<li><a href="Fluorouracil.htm" tppabs="https://ptable.com/wiki/compounds/A/Fluorouracil" title="Fluorouracil">Fluorouracil</a><sup>#</sup></li>
<li><a href="Tegafur.htm" tppabs="https://ptable.com/wiki/compounds/A/Tegafur" title="Tegafur">Tegafur</a> (+gimeracil/oteracil))</li></ul>

<ul><li><i>DNA polymerase inhibitor</i> (<a href="Cytarabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Cytarabine" title="Cytarabine">Cytarabine</a><sup>#</sup>)</li></ul>

<ul><li><i>Ribonucleotide reductase inhibitor</i> (<a href="Gemcitabine.htm" tppabs="https://ptable.com/wiki/compounds/A/Gemcitabine" title="Gemcitabine">Gemcitabine</a><sup>#</sup>)</li></ul>

<ul><li><i>Hypomethylating agent</i> (<a href="Azacitidine.htm" tppabs="https://ptable.com/wiki/compounds/A/Azacitidine" title="Azacitidine">Azacitidine</a></li>
<li>Decitabine)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Deoxyribonucleotide</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Ribonucleotide reductase inhibitor</i> (<a href="Hydroxycarbamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydroxycarbamide" title="Hydroxycarbamide">Hydroxycarbamide</a><sup>#</sup>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Topoisomerase inhibitors<br>(S phase)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">I</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Camptotheca</i> (Belotecan</li>
<li><a href="Camptothecin.htm" tppabs="https://ptable.com/wiki/compounds/A/Camptothecin" title="Camptothecin">Camptothecin</a></li>
<li><span class="new">Cositecan</span><sup>†</sup></li>
<li>Exatecan</li>
<li><span class="new">Gimatecan</span></li>
<li><a href="Irinotecan.htm" tppabs="https://ptable.com/wiki/compounds/A/Irinotecan" title="Irinotecan">Irinotecan</a><sup>#</sup></li>
<li>Lurtotecan<sup>‡</sup></li>
<li>Rubitecan<sup>‡</sup></li>
<li><span class="new">Silatecan</span><sup>§</sup></li>
<li>Topotecan)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">II</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Podophyllum</i> (<a href="Etoposide.htm" tppabs="https://ptable.com/wiki/compounds/A/Etoposide" title="Etoposide">Etoposide</a><sup>#</sup></li>
<li><a href="Teniposide.htm" tppabs="https://ptable.com/wiki/compounds/A/Teniposide" title="Teniposide">Teniposide</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">II+Intercalation</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Anthracyclines</i> (Aclarubicin</li>
<li>Amrubicin<sup>†</sup></li>
<li><a href="Daunorubicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Daunorubicin" title="Daunorubicin">Daunorubicin</a><sup>#</sup></li>
<li><a href="Doxorubicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Doxorubicin" title="Doxorubicin">Doxorubicin</a><sup>#</sup></li>
<li><a href="Epirubicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Epirubicin" title="Epirubicin">Epirubicin</a></li>
<li><a href="Idarubicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Idarubicin" title="Idarubicin">Idarubicin</a></li>
<li><a href="Pirarubicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Pirarubicin" title="Pirarubicin">Pirarubicin</a></li>
<li><a href="Valrubicin.htm" tppabs="https://ptable.com/wiki/compounds/A/Valrubicin" title="Valrubicin">Valrubicin</a></li>
<li>Zorubicin)</li>
<li><i><a href="Anthraquinone.htm" tppabs="https://ptable.com/wiki/compounds/A/Anthraquinone" title="Anthraquinone">Anthracenediones</a></i> (<a href="Mitoxantrone.htm" tppabs="https://ptable.com/wiki/compounds/A/Mitoxantrone" title="Mitoxantrone">Mitoxantrone</a></li>
<li>Pixantrone)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Crosslinking of DNA<br>(CCNS)</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Alkylating</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>Nitrogen mustards:</i> Bendamustine<sup>#</sup></li>
<li>Chlormethine</li>
<li><a href="Cyclophosphamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Cyclophosphamide" title="Cyclophosphamide">Cyclophosphamide</a><sup>#</sup> (<a href="Ifosfamide.htm" tppabs="https://ptable.com/wiki/compounds/A/Ifosfamide" title="Ifosfamide">Ifosfamide</a><sup>#</sup></li>
<li>Trofosfamide)</li>
<li><a href="Chlorambucil.htm" tppabs="https://ptable.com/wiki/compounds/A/Chlorambucil" title="Chlorambucil">Chlorambucil</a><sup>#</sup> (<a href="Melphalan.htm" tppabs="https://ptable.com/wiki/compounds/A/Melphalan" title="Melphalan">Melphalan</a></li>
<li><a href="Prednimustine.htm" tppabs="https://ptable.com/wiki/compounds/A/Prednimustine" title="Prednimustine">Prednimustine</a>)</li>
<li><a href="Uramustine.htm" tppabs="https://ptable.com/wiki/compounds/A/Uramustine" title="Uramustine">Uramustine</a></li></ul>

<ul><li><i>Nitrosoureas:</i> <a href="Carmustine.htm" tppabs="https://ptable.com/wiki/compounds/A/Carmustine" title="Carmustine">Carmustine</a></li>
<li><a href="Fotemustine.htm" tppabs="https://ptable.com/wiki/compounds/A/Fotemustine" title="Fotemustine">Fotemustine</a></li>
<li><a href="Lomustine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lomustine" title="Lomustine">Lomustine</a> (<a href="Semustine.htm" tppabs="https://ptable.com/wiki/compounds/A/Semustine" title="Semustine">Semustine</a>)</li>
<li>Nimustine</li>
<li>Ranimustine</li>
<li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Streptozotocin  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Streptozotocin'" tppabs="https://ptable.com/wiki/compounds/A/Streptozotocin" title="Streptozotocin">Streptozocin</a></li></ul>

<ul><li><i>Alkyl sulfonates:</i> <a href="Busulfan.htm" tppabs="https://ptable.com/wiki/compounds/A/Busulfan" title="Busulfan">Busulfan</a> (Mannosulfan</li>
<li><a href="Treosulfan.htm" tppabs="https://ptable.com/wiki/compounds/A/Treosulfan" title="Treosulfan">Treosulfan</a>)</li></ul>

<ul><li><i><a href="Aziridine.htm" tppabs="https://ptable.com/wiki/compounds/A/Aziridine" title="Aziridine">Aziridines</a>:</i> Carboquone</li>
<li>Thiotepa</li>
<li><a href="Triaziquone.htm" tppabs="https://ptable.com/wiki/compounds/A/Triaziquone" title="Triaziquone">Triaziquone</a></li>
<li><a href="Triethylenemelamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Triethylenemelamine" title="Triethylenemelamine">Triethylenemelamine</a></li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Platinum-based</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Carboplatin  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Carboplatin'" tppabs="https://ptable.com/wiki/compounds/A/Carboplatin" title="Carboplatin">Carboplatin</a><sup>#</sup></li>
<li><a href="Cisplatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Cisplatin" title="Cisplatin">Cisplatin</a><sup>#</sup></li>
<li>Dicycloplatin</li>
<li>Nedaplatin</li>
<li><a href="Oxaliplatin.htm" tppabs="https://ptable.com/wiki/compounds/A/Oxaliplatin" title="Oxaliplatin">Oxaliplatin</a><sup>#</sup></li>
<li>Satraplatin</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Nonclassical</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Altretamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Altretamine" title="Altretamine">Altretamine</a></li>
<li><i><a href="Hydrazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Hydrazine" title="Hydrazine">Hydrazines</a></i> (<a href="Procarbazine.htm" tppabs="https://ptable.com/wiki/compounds/A/Procarbazine" title="Procarbazine">Procarbazine</a><sup>#</sup>)</li>
<li><a href="Mitobronitol.htm" tppabs="https://ptable.com/wiki/compounds/A/Mitobronitol" title="Mitobronitol">Mitobronitol</a></li>
<li><a href="Pipobroman.htm" tppabs="https://ptable.com/wiki/compounds/A/Pipobroman" title="Pipobroman">Pipobroman</a></li>
<li><i>Triazenes</i> (<a href="javascript:if(confirm('https://ptable.com/wiki/compounds/A/Dacarbazine  \n\nThis file was not retrieved by Teleport VLX, because it was unavailable, or its retrieval was aborted, or the project was stopped too soon.  \n\nDo you want to open it from the server?'))window.location='https://ptable.com/wiki/compounds/A/Dacarbazine'" tppabs="https://ptable.com/wiki/compounds/A/Dacarbazine" title="Dacarbazine">Dacarbazine</a><sup>#</sup></li>
<li><a href="Temozolomide.htm" tppabs="https://ptable.com/wiki/compounds/A/Temozolomide" title="Temozolomide">Temozolomide</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Intercalation</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li>Streptomyces (<a href="Actinomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Actinomycin" title="Actinomycin" class="mw-redirect">Actinomycin</a><sup>#</sup></li>
<li><a href="Bleomycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Bleomycin" title="Bleomycin">Bleomycin</a><sup>#</sup></li>
<li>Mitomycins</li>
<li><a href="Plicamycin.htm" tppabs="https://ptable.com/wiki/compounds/A/Plicamycin" title="Plicamycin">Plicamycin</a>)</li></ul>
</div></td></tr></tbody></table><div></div></td></tr></tbody></table><div></div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Photosensitizers/PDT</th><td class="navbox-list navbox-even hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Aminolevulinic_acid.htm" tppabs="https://ptable.com/wiki/compounds/A/Aminolevulinic_acid" title="Aminolevulinic acid">Aminolevulinic acid</a><span>&nbsp;</span>/ <a href="Methyl_aminolevulinate.htm" tppabs="https://ptable.com/wiki/compounds/A/Methyl_aminolevulinate" title="Methyl aminolevulinate">Methyl aminolevulinate</a></li>
<li>Efaproxiral</li>
<li>Padeliporfin</li>
<li><i><a href="Porphyrin.htm" tppabs="https://ptable.com/wiki/compounds/A/Porphyrin" title="Porphyrin">Porphyrin derivatives</a></i> (<a href="Porfimer_sodium.htm" tppabs="https://ptable.com/wiki/compounds/A/Porfimer_sodium" title="Porfimer sodium">Porfimer sodium</a></li>
<li>Talaporfin</li>
<li>Temoporfin</li>
<li><a href="Verteporfin.htm" tppabs="https://ptable.com/wiki/compounds/A/Verteporfin" title="Verteporfin">Verteporfin</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other</th><td class="navbox-list navbox-odd hlist" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em"></div><table class="nowraplinks navbox-subgroup" style="border-spacing:0"><tbody><tr><th scope="row" class="navbox-group" style="width:1%">Enzyme inhibitors</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>FI</i> (Tipifarnib<sup>§</sup>)</li>
<li><i>CDK inhibitors</i> (Abemaciclib</li>
<li>Alvocidib<sup>†</sup></li>
<li>Palbociclib</li>
<li>Ribociclib</li>
<li>Seliciclib<sup>†</sup>)</li>
<li><i>PrI</i>
<ul><li><a href="Bortezomib.htm" tppabs="https://ptable.com/wiki/compounds/A/Bortezomib" title="Bortezomib">Bortezomib</a></li>
<li>Carfilzomib</li>
<li>Ixazomib</li></ul></li>
<li><i>PhI</i> (<a href="Anagrelide.htm" tppabs="https://ptable.com/wiki/compounds/A/Anagrelide" title="Anagrelide">Anagrelide</a>)</li>
<li><i>IMPDI</i> (Tiazofurin<sup>§</sup>)</li>
<li><i>LI</i> (<a href="Masoprocol.htm" tppabs="https://ptable.com/wiki/compounds/A/Masoprocol" title="Masoprocol">Masoprocol</a>)</li>
<li><i>PARP inhibitor</i> (Niraparib</li>
<li>Olaparib</li>
<li>Rucaparib)</li>
<li><i>HDAC</i> (Belinostat</li>
<li>Panobinostat</li>
<li>Romidepsin</li>
<li><a href="Vorinostat.htm" tppabs="https://ptable.com/wiki/compounds/A/Vorinostat" title="Vorinostat">Vorinostat</a>)</li>
<li><i>PIKI</i> (Alpelisib</li>
<li>Idelalisib)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Receptor antagonists</th><td class="navbox-list navbox-even" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><i>ERA</i> (Atrasentan)</li>
<li><i>Retinoid X receptor</i> (<a href="Bexarotene.htm" tppabs="https://ptable.com/wiki/compounds/A/Bexarotene" title="Bexarotene">Bexarotene</a>)</li>
<li><i>Sex steroid</i> (<a href="Testolactone.htm" tppabs="https://ptable.com/wiki/compounds/A/Testolactone" title="Testolactone">Testolactone</a>)</li></ul>
</div></td></tr><tr><th scope="row" class="navbox-group" style="width:1%">Other/ungrouped</th><td class="navbox-list navbox-odd" style="text-align:left;border-left-width:2px;border-left-style:solid;width:100%;padding:0px"><div style="padding:0em 0.25em">
<ul><li><a href="Amsacrine.htm" tppabs="https://ptable.com/wiki/compounds/A/Amsacrine" title="Amsacrine">Amsacrine</a></li>
<li><a href="Arsenic_trioxide.htm" tppabs="https://ptable.com/wiki/compounds/A/Arsenic_trioxide" title="Arsenic trioxide">Arsenic trioxide</a></li>
<li><i><a href="Asparagine.htm" tppabs="https://ptable.com/wiki/compounds/A/Asparagine" title="Asparagine">Asparagine depleters</a></i> (<a href="Asparaginase.htm" tppabs="https://ptable.com/wiki/compounds/A/Asparaginase" title="Asparaginase">Asparaginase</a><sup>#</sup>/<a href="Pegaspargase.htm" tppabs="https://ptable.com/wiki/compounds/A/Pegaspargase" title="Pegaspargase">Pegaspargase</a>)</li>
<li><a href="Celecoxib.htm" tppabs="https://ptable.com/wiki/compounds/A/Celecoxib" title="Celecoxib">Celecoxib</a></li>
<li><a href="Demecolcine.htm" tppabs="https://ptable.com/wiki/compounds/A/Demecolcine" title="Demecolcine">Demecolcine</a></li>
<li>Elesclomol<sup>§</sup></li>
<li>Elsamitrucin</li>
<li>Eribulin</li>
<li>Estramustine phosphate</li>
<li><a href="Etoglucid.htm" tppabs="https://ptable.com/wiki/compounds/A/Etoglucid" title="Etoglucid">Etoglucid</a></li>
<li><a href="Lonidamine.htm" tppabs="https://ptable.com/wiki/compounds/A/Lonidamine" title="Lonidamine">Lonidamine</a></li>
<li>Lucanthone</li>
<li>Mitoguazone</li>
<li><a href="Mitotane.htm" tppabs="https://ptable.com/wiki/compounds/A/Mitotane" title="Mitotane">Mitotane</a></li>
<li>Oblimersen<sup>†</sup></li>
<li>Omacetaxine mepesuccinate</li>
<li>Trabectedin</li>
<li><i>Retinoids</i> (<a href="Alitretinoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Alitretinoin" title="Alitretinoin">Alitretinoin</a></li>
<li><a href="Tretinoin.htm" tppabs="https://ptable.com/wiki/compounds/A/Tretinoin" title="Tretinoin">Tretinoin</a><sup>#</sup>)</li>
<li>Venetoclax</li></ul>
</div></td></tr></tbody></table><div></div></td></tr><tr><td class="navbox-abovebelow" colspan="2" style="background: transparent; padding: 0px;"><div><div class="hlist">
<ul><li><sup>#</sup>WHO-EM</li>
<li><sup>‡</sup>Withdrawn from market</li>
<li>Clinical trials:
<ul><li><sup>†</sup>Phase III</li>
<li><sup>§</sup>Never to phase III</li></ul></li></ul>
</div></div></td></tr></tbody></table></div>











<style data-mw-deduplicate="TemplateStyles:r951705291">.mw-parser-output cite.citation{font-style:inherit}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/6/65/Lock-green.svg/9px-Lock-green.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/d/d6/Lock-gray-alt-2.svg/9px-Lock-gray-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/a/aa/Lock-red-alt-2.svg/9px-Lock-red-alt-2.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg*/);background-repeat:no-repeat;background-size:9px;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-ws-icon a{background-image:url("../../../../upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png"/*tpa=https://upload.wikimedia.org/wikipedia/commons/thumb/4/4c/Wikisource-logo.svg/12px-Wikisource-logo.svg.png*/);background-image:linear-gradient(transparent,transparent),url("../../../../upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg"/*tpa=https://upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg*/);background-repeat:no-repeat;background-size:12px;background-position:right .1em center}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{font-size:100%}.mw-parser-output .cs1-maint{display:none;color:#33aa33;margin-left:0.3em}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}</style>
    
</details><!--htdig_noindex--><div><div style="clear:both; background-image:linear-gradient(180deg, #E8E8E8, white); border-top: dashed 2px #AAAAAA; padding: 0.5em 0.5em 0.5em 0.5em; margin-top: 1em; direction: ltr;">
    This article is issued from <a class="external text" title="Last edited on 2020-08-06" href="javascript:if(confirm('https://en.wikipedia.org/wiki/?title=Temozolomide&oldid=971426010  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://en.wikipedia.org/wiki/?title=Temozolomide&oldid=971426010'" tppabs="https://en.wikipedia.org/wiki/?title=Temozolomide&oldid=971426010">Wikipedia</a>. The text is licensed under <a class="external text" href="javascript:if(confirm('https://creativecommons.org/licenses/by-sa/4.0/  \n\nThis file was not retrieved by Teleport VLX, because it is addressed on a domain or path outside the boundaries set for its Starting Address.  \n\nDo you want to open it from the server?'))window.location='https://creativecommons.org/licenses/by-sa/4.0/'" tppabs="https://creativecommons.org/licenses/by-sa/4.0/">Creative Commons - Attribution - Sharealike</a>. Additional terms may apply for the media files.
</div>
</div><!--/htdig_noindex--></div>
        </div>
      </div>
    </div>
  </div>
  <script src="../-/j/js_modules/jsConfigVars.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jsConfigVars.js" class=""></script>
  <script src="../-/j/js_modules/startup.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/startup.js" class=""></script>
<script src="../-/j/js_modules/jquery.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/jquery.js" class=""></script>
<script src="../-/j/js_modules/mediawiki.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/mediawiki.js" class=""></script>
<script src="../-/j/js_modules/site.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/site.js" class=""></script>
<script src="../-/j/js_modules/ext.cite.ux-enhancements.js" tppabs="https://ptable.com/wiki/compounds/-/j/js_modules/ext.cite.ux-enhancements.js" class=""></script>



</body></html>